Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gábor Heltovics"'
Publikováno v:
Acta Pharmaceutica Hungarica. 91:234-235
Autor:
Tamás Solymosi, Orsolya Basa-Dénes, Réka Angi, Tamás Jordán, Hristos Glavinas, Andrea Ujhelyi, Gábor Heltovics, Zsolt Ötvös
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 129
Abiraterone acetate is indicated for patients with metastatic castration resistant prostate cancer. The marketed drug product (Zytiga®) exhibits very low bioavailability in the fasted state and a substantial positive food effect. We recently develop
Autor:
Zsolt Ötvös, Ann Church, Hristos Glavinas, Tamás Jordán, László Molnár, Tamás Solymosi, John McDermott, Stuart Mair, Genovéva Filipcsei, Vanessa Zann, Betti Ordasi, Gábor Heltovics, Réka Angi
Publikováno v:
Cancer chemotherapy and pharmacology. 80(4)
Zytiga (abiraterone acetate, AA) is known to exhibit very low bioavailability and a significant positive food effect in men. The unfavorable pharmacokinetic properties are attributed to the inadequate and variable dissolution of the compound. Using a
Autor:
Réka Angi, Tamás Solymosi, Soma Ránky, Zsolt Ötvös, Betti Ordasi, Tamás Jordán, László Molnár, Gábor Heltovics, Sándor Semsey, Genovéva Filipcsei, Hristos Glavinas
Publikováno v:
International journal of pharmaceutics. 532(1)
Particle size reduction of drug crystals in the presence of surfactants (often called "top-down" production methods) is a standard approach used in the pharmaceutical industry to improve bioavailability of poorly soluble drugs. Based on the mathemati
Autor:
Chris Roe, Litza McKenzie, Gábor Heltovics, Tamás Solymosi, Hristos Glavinas, Orsolya Basa-Dénes, Balázs Kárpáti, Réka Angi, Tamás Jordán, John McDermott
Publikováno v:
Journal of Clinical Oncology. 36:e16555-e16555
e16555Background: Rapamune (Sirolimus) exhibits low bioavailability and high variability following oral administration. Reaching the therapeutic blood concentrations in renal cancer patients was fo...
Autor:
Réka Angi, Hristos Glavinas, László Molnár, Tamás Solymosi, Ann Church, Stuart Mair, Tamás Jordán, Betti Ordasi, Genovéva Filipcsei, Vanessa Zann, John McDermott, Gábor Heltovics, Zsolt Ötvös
Publikováno v:
Journal of Clinical Oncology. 36:e17036-e17036
e17036Background: Zytiga (Abiraterone acetate, AA) is known to exhibit very low bioavailability and a significant positive food effect. This is attributed to the inadequate and variable dissolution...
Autor:
Gábor Heltovics, Orsolya Basa-Dénes, Hristos Glavinas, Soma Ránky, Zsolt Ötvös, Réka Angi, Tamás Solymosi, Genovéva Filipcsei
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 94
The oral bioavailability of Sirolimus is limited by poor dissolution of the compound in the gastrointestinal tract resulting in a low bioavailability and large inter-individual differences in blood levels. Several different formulation approaches wer
Autor:
Genovéva Filipcsei, Betti Ordasi, Tamás Solymosi, Réka Angi, Ferenc Darvas, Gábor Heltovics, Hristos Glavinas, Zsolt Ötvös
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 86(3)
The oral bioavailability of Aprepitant is limited by poor dissolution of the compound in the gastrointestinal tract which is more prominent in the fasted state resulting in significant positive food effect. Due to the low aqueous solubility of the ac